Vitamin D Research

back to research menu

Epilepsy

• Benefits of sunlight: Vitamin D deficiency might increase the risk of sudden unexpected death in epilepsy. Med Hypotheses. 2010 Jan;74(1):158–61.
• Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg. 2009 Nov 11.
• Should enzyme-inducing antiepileptic drugs be considered first-line agents? Epilepsia. 2009 Sep;50 Suppl 8:42–50. Review.
• Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children. Dev Med Child Neurol. 2009 Aug 26.
• A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy. Eur J Neurol. 2009 Aug 13.
• Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug. Bone. 2009 Aug;45(2):232–7.
• Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009 Jun 20.
• Possible methods for the prevention of bone loss in persons with epilepsy. Expert Rev Neurother. 2009 Jun;9(6):797–812.
• Case 3-2009: a 9-month-old boy with seizures. N Engl J Med. 2009 Apr 9;360(15):1572–3; author reply 1573–4.
• Case 3-2009: a 9-month-old boy with seizures. N Engl J Med. 2009 Apr 9;360(15):1572; author reply 1573–4.
• Deletion of the citron kinase gene selectively affects the number and distribution of interneurons in barrelfield cortex. J Comp Neurol. 2009 Apr 1;513(4):spc1.
• Neuronal hyperactivity sustains the basal dendrites of immature dentate granule cells: time-lapse confocal analysis using hippocampal slice cultures. Hippocampus. 2009 Apr;19(4):379–91.
• Ontogeny of calbindin immunoreactivity in the human hippocampal formation with a special emphasis on granule cells of the dentate gyrus. Int J Dev Neurosci. 2009 Apr;27(2):115–27.
• Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J Neuropathol Exp Neurol. 2009 Apr;68(4):356–64.
• Re: Epilepsy-associated bone mineral density loss should be prevented. Neurology. 2009 Mar 10;72(10):943; author reply 943–4.
• Proteomic analysis of cerebrospinal fluid from patients with idiopathic temporal lobe epilepsy. Brain Res. 2009 Feb 19;1255:180–9.
• Case records of the Massachusetts General Hospital. Case 3-2009. A 9-month-old boy with seizures. N Engl J Med. 2009 Jan 22;360(4):398–407.
• Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr. 2008 Dec;88(6):1678–84.
• Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy. Eur J Pediatr. 2008 Dec;167(12):1369–77.
• Evaluation of bone turnover in epileptic children using oxcarbazepine. Pediatr Neurol. 2008 Oct;39(4):266–71.
• Antiepileptic drug use and rates of hip bone loss in older men: a prospective study. Neurology. 2008 Sep 2;71(10):723–30.
• Changes in bone turnover, bone mineral and fracture risk induced by drugs used to treat epilepsy. Curr Drug Saf. 2008 Sep;3(3):168–72. Review.
• Expression of vitamin D receptor mRNA in the hippocampal formation of rats submitted to a model of temporal lobe epilepsy induced by pilocarpine. Brain Res Bull. 2008 Jul 30;76(5):480–4.
• Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright's hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid. Am J Med Sci. 2008 Jul;336(1):84–90.
• Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone. 2008 Jul;43(1):149–55.
• Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium-binding proteins. Bone. 2008 Jul;43(1):149–55.
• Altered spatial distribution of PV-cortical cells and dysmorphic neurons in the somatosensory cortex of BCNU-treated rat model of cortical dysplasia. Epilepsia. 2008 May;49(5):872–87.
• Long-term decrease in calbindin-D28K expression in the hippocampus of epileptic rats following pilocarpine-induced status epilepticus. Epilepsy Res. 2008 May;79(2–3):213–23.
• Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology. 2008 Apr 29;70(18):1586–93.
• Supracondylar femur fracture complicating epileptic insult: a specific and under diagnosed complication? Acta Neurol Belg. 2008 Mar;108(1):17–20.
• Ward round—seizures, tremor and muscle weakness 20 years after thyroid surgery. Malawi Med J. 2008 Mar;20(1):29, 34–5.
• Nutritional problems related to food allergy in childhood. Pediatr Allergy Immunol. 2008 Mar;19(2):188–95.
• Bone health in people with epilepsy: is it impaired and what are the risk factors? Seizure. 2008 Mar;17(2):181–6. Review.
• Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants. Development. 2008 Feb;135(3):541–57.
• Cognitive impairment and epilepsy seizure caused by hypoparathyroidism. Bratisl Lek Listy. 2008;109(2):79–81.
• Bone health in women with epilepsy: clinical features and potential mechanisms. Int Rev Neurobiol. 2008;83:305–28. Review.
• Importance of monotherapy in women across the reproductive cycle. Neurology. 2007 Dec 11;69(24 Suppl 3):S10–6. Review.
• Fractures and handicap in an adult population: A clinical study. Joint Bone Spine. 2007 Dec;74(6):584–9.
• Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol. 2007 Dec;14(4):196–200. Review.
• Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock. Eur J Pharmacol. 2007 Nov 14;573(1–3):111–5.
• Hypocalcaemic fit in an adolescent boy with undiagnosed rickets. Emerg Med J. 2007 Nov;24(11):778–9.
• Distribution of neuronal nitric oxide synthase (nNOS)-immunoreactive elements in the rabbit piriform cortex. Folia Morphol (Warsz). 2007 Nov;66(4):296–302.
• Maternal vitamin D deficiency associated with neonatal hypocalcaemic convulsions. Nutr J. 2007 Sep 19;6:23.
• Congenital rickets presenting with hypocalcaemic seizures. West Indian Med J. 2007 Sep;56(4):364–7.
• Vitamin D 1alpha-hydroxylase gene mutations in patients with 1alpha-hydroxylase deficiency. J Clin Endocrinol Metab. 2007 Aug;92(8):3177–82.
• Hypocalcemic seizure due to congenital rickets in the first day of life. Turk J Pediatr. 2007 Jul–Sep;49(3):301–3.
• Antiepileptic drug-induced osteopathy. Subtypes, pathogenesis, prevention, early diagnosis and treatment. Dtsch Med Wochenschr. 2007 Jul 29;132(27):1475–9. Review.
• Mossy cell axon synaptic contacts on ectopic granule cells that are born following pilocarpine-induced seizures. Neurosci Lett. 2007 Jul 11;422(2):136–40.
• Morphologic and neurochemical alterations in the superior colliculus of the genetically epilepsy-prone hamster (GPG/Vall). Epilepsy Res. 2007 Jul;75(2–3):206–19.
• Adverse effects of antiepileptic drugs on bone mineral density in children. Expert Opin Drug Saf. 2007 May;6(3):267–78. Review.
• Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy. Arq Bras Endocrinol Metabol. 2007 Apr;51(3):466–71.
• Inhibitory networks in epilepsy-associated gangliogliomas and in the perilesional epileptic cortex. Epilepsy Res. 2007 Apr;74(1):33–44.
• Natural approaches to epilepsy. Altern Med Rev. 2007 Mar;12(1):9–24. Review.
• A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav. 2007 Mar;10(2):291–5.
• Anti-epileptic medication and bone health. Osteoporos Int. 2007 Feb;18(2):129–42. Review.
• Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet. Epilepsia. 2007 Jan;48(1):66–71.
• Homocysteine and bone loss in epilepsy. Seizure. 2007 Jan;16(1):22–34.
• Injections of vehicle, but not cyclosporin A or tacrolimus (FK506), afford neuroprotection following injury in the developing rat brain. Acta Neurobiol Exp (Wars). 2007;67(4):399–409.
• Ectopic granule cells of the rat dentate gyrus. Dev Neurosci. 2007;29(1–2):14–27. Review.
• Restoration of calbindin after fetal hippocampal CA3 cell grafting into the injured hippocampus in a rat model of temporal lobe epilepsy. Hippocampus. 2007;17(10):943–56.
• Loss of input from the mossy cells blocks maturation of newly generated granule cells. Hippocampus. 2007;17(7):510–24.
• Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neurology. 2006 Dec 12;67(11):2005–14.
• Anomalous inhibitory circuits in cortical tubers of human tuberous sclerosis complex associated with refractory epilepsy: aberrant expression of parvalbumin and calbindin-D28k in dysplastic cortex. J Child Neurol. 2006 Dec;21(12):1058–63.
• Firing pattern and calbindin-D28k content of human epileptic granule cells. Brain Res. 2006 Nov 20;1120(1):191–201.
• Hypocalcemic seizures and secondary bilateral femoral fractures in an adolescent with primary vitamin D deficiency. Pediatrics. 2006 Nov;118(5):2226–30.
• Antiepileptic drugs and bone metabolism. Nutr Metab (Lond). 2006 Sep 6;3(1):36.
• Hypoparathyroidism-induced epilepsy: an overlooked cause. Am J Emerg Med. 2006 Sep;24(5):617–8.
• Hypoparathyroidism: a rare treatable cause of epilepsy — report of two cases. Eur J Neurol. 2006 Jul;13(7):786–8.
• Recent studies on vitamin D metabolizing enzymes. Clin Calcium. 2006 Jul;16(7):1129–35. Review.
• Architectural (Type IA) focal cortical dysplasia and parvalbumin immunostaining in temporal lobe epilepsy. Epilepsia. 2006 Jun;47(6):1074–8.
• Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy. J Child Neurol. 2006 May;21(5):411–4.
• Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia. 2006 Mar;47(3):510–5.
• Hypocalcemia due to vitamin D deficiency in exclusively breastfed infants. Indian Pediatr. 2006 Mar;43(3):247–51.
• Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study. J Child Neurol. 2006 Mar;21(3):205–9.
• A survey of vitamin D level in people with learning disability in long-stay hospital wards in Hong Kong. J Intellect Disabil. 2006 Mar;10(1):47–59.
• Vitamin D deficiency in the San Francisco Bay Area. J Pediatr Endocrinol Metab. 2006 Mar;19(3):205–8.
• Increased severity of chemically induced seizures in mice with partially deleted Vitamin D receptor gene. Neurosci Lett. 2006 Feb 6;394(1):69–73.
• Reorganization of CA3 area of the mouse hippocampus after pilocarpine induced temporal lobe epilepsy with special reference to the CA3-septum pathway. J Neurosci Res. 2006 Feb 1;83(2):318–31.
• Neonatal pseudohypoparathyroidism. Indian J Pediatr. 2006 Jan;73(1):97–8.
• Epilepsy-related injuries. Epilepsia. 2006;47 Suppl 1:79–86. Review.
• Might calcium disorders cause or contribute to myoclonic seizures in epileptics' Med Hypotheses. 2006;66(5):969–74.
• Mossy fibers are the primary source of afferent input to ectopic granule cells that are born after pilocarpine-induced seizures. Exp Neurol. 2005 Dec;196(2):316–31.
• Seizures induce proliferation and dispersion of doublecortin-positive hippocampal progenitor cells. Exp Neurol. 2005 Dec;196(2):342–51.
• Klinefelter's syndrome with seizure, pseudohypoparathyroidism type Ib and multiple endocrine dysfunctions. J Chin Med Assoc. 2005 Dec;68(12):585–90.
• Effect of carbamazepine and valproate on bone metabolism in children with epilepsy. Zhonghua Er Ke Za Zhi. 2005 Oct;43(10):728–32.
• Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res Bull. 2005 Sep 30;67(1–2):156–60.
• Fit for a fracture. Med J Aust. 2005 Aug 15;183(4):213–4.
• Management of women with epilepsy: Are guidelines being followed' Results from case-note reviews and a patient questionnaire. Epilepsia. 2005 Aug;46(8):1286–92.
• Tetanic crisis and antiepileptic drugs. A case report. Neuro Endocrinol Lett. 2005 Aug;26(4):317–9.
• Effects of Treatment on Endocrine Function in Patients with Epilepsy. Curr Treat Options Neurol. 2005 Jul;7(4):273–280.
• Ketogenic diet increases calbindin-D28k in the hippocampi of male ICR mice with kainic acid seizures. Epilepsy Res. 2005 Jul;65(3):153–9.
• Epileptogenesis and chronic seizures in a mouse model of temporal lobe epilepsy are associated with distinct EEG patterns and selective neurochemical alterations in the contralateral hippocampus. Exp Neurol. 2005 Jul;194(1):76–90.
• Hypocalcemic seizures secondary to nutritional vitamin D deficiency in 3 infants fed soy formula. Clin Pediatr (Phila). 2005 Jun;44(5):455–7.
• Impaired and repaired inhibitory circuits in the epileptic human hippocampus. Trends Neurosci. 2005 Jun;28(6):334–40. Review.
• Effects of GABAergic transmissions on the immunoreactivities of calcium binding proteins in the gerbil hippocampus. J Comp Neurol. 2005 May 2;485(2):153–64.
• Vitamins for epilepsy. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004304. Review.
• Effect of kainate-induced experimental epilepsy on NADPH-diaphorase and calcium-binding proteins in rat hippocampal neurons. Bull Exp Biol Med. 2005 Mar;139(3):309–12.
• Pediatric hypocalcemic seizures: a case of rickets. J Emerg Med. 2005 Feb;28(2):161–4.
• Seizures in foreign newborns due to maternal vitamin-D deficiency. Ned Tijdschr Geneeskd. 2005 Jan 29;149(5):257–60.
• Paroxysmal dyskinesia with secondary generalization of tonic-clonic seizures in pseudohypoparathyroidism. Epilepsia. 2005 Jan;46(1):164–5.
• Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr. 2004 Dec;62(4):940–8.
• Changes of calbindin D-28k immunoreactivity in the hippocampus after adrenalectomy in the seizure sensitive gerbil. Anat Histol Embryol. 2004 Oct;33(5):299–303.
• Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: distinct patterns of storage deposition, neurodegeneration and glial activation. Brain Pathol. 2004 Oct;14(4):349–57.
• Static, transient and permanent organization of GABA receptor expression in calbindin-positive interneurons in response to amygdala kindled seizures. J Neurochem. 2004 Oct;91(1):144–54.
• Images in emergency medicine. Nutritional rickets resulting from vitamin D deficiency contributing to hypocalcemic seizures. Ann Emerg Med. 2004 Jul;44(1):86, 95.
• Bone disease in epilepsy. Curr Neurol Neurosci Rep. 2004 Jul;4(4):329–34. Review.
• Loss of seizure control due to anticonvulsant-induced hypocalcemia. Ann Pharmacother. 2004 Jun;38(6):1002–5.
• Progression of temporal lobe epilepsy in the rat is associated with immunocytochemical changes in inhibitory interneurons in specific regions of the hippocampal formation. Exp Neurol. 2004 Jun;187(2):367–79.
• Idiopathic hypoparathyroidism and adhesive capsulitis of the shoulder in two first-degree relatives. Joint Bone Spine. 2004 May;71(3):234–6.
• Long-term behavioral and morphological consequences of nonconvulsive status epilepticus in rats. Epilepsy Behav. 2004 Apr;5(2):180–91.
• Recommendations for the care of women with epilepsy. Cleve Clin J Med. 2004 Feb;71 Suppl 2:S49–57. Review.
• Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav. 2004 Feb;5 Suppl 2:S41–7.
• Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav. 2004 Feb;5 Suppl 2:S36–40. Review.
• Epilepsy and bone health in adults. Epilepsy Behav. 2004 Feb;5 Suppl 2:S24–9. Review.
• Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav. 2004 Feb;5 Suppl 2:S3–15.
• Changes in the expression of calbindin D-28k in the gerbil hippocampus following seizure. Neurochem Int. 2004 Feb;44(3):145–52.
• Variable presentations of rickets in children in the emergency department. Pediatr Emerg Care. 2004 Feb;20(2):126–30.
• Histopathology and reorganization of chandelier cells in the human epileptic sclerotic hippocampus. Brain. 2004 Jan;127(Pt 1):45–64.
• Down syndrome and epilepsy: a nutritional connection' Med Hypotheses. 2004;62(1):35–44.
• Mice deficient for the extracellular matrix glycoprotein tenascin-r show physiological and structural hallmarks of increased hippocampal excitability, but no increased susceptibility to seizures in the pilocarpine model of epilepsy. Neuroscience. 2004;124(4):841–55.
• Glutamate and GABA concentrations in the cerebellum of novel ataxic mutant Pogo mice. J Vet Sci. 2003 Dec;4(3):209–12.
• Transient calretinin expression defines early postmitotic step of neuronal differentiation in adult hippocampal neurogenesis of mice. Mol Cell Neurosci. 2003 Nov;24(3):603–13.
• Clinical reasoning and decision making in practice. A man with unilateral attacks of muscular rigidity following neck surgery for a malignant tumor. Ned Tijdschr Geneeskd. 2003 Oct 25;147(43):2118–22.
• Carbamazepine does not alter biochemical parameters of bone turnover in healthy male adults. Calcif Tissue Int. 2003 Oct;73(4):356–60.
• Menopause and bone density issues for women with epilepsy. Neurology. 2003 Sep 1;61(6 Suppl 2):S16–22. Review.
• Glutamate receptor subunit 3 (GluR3) immunoreactivity delineates a subpopulation of parvalbumin-containing interneurons in the rat hippocampus. J Comp Neurol. 2003 Jul 14;462(1):15–28.
• Dentate granule cell neurogenesis after seizures induced by pentylenetrazol in rats. Brain Res. 2003 Jul 11;977(2):141–8.
• Cajal-Retzius cells, inhibitory interneuronal populations and neuropeptide Y expression in focal cortical dysplasia and microdysgenesis. Acta Neuropathol. 2003 Jun;105(6):561–9.
• Seizures as the presenting feature of rickets in an infant. Med J Aust. 2003 May 5;178(9):467; discussion 467–8.
• Suspected pseudohypoparathyroidism in a domestic ferret. J Am Vet Med Assoc. 2003 Apr 15;222(8):1093–6, 1077.
• Symptomatic antiepileptic drug associated vitamin D deficiency in noninstitutionalized patients: an under-diagnosed disorder. J Med Liban. 2003 Apr–Jun;51(2):71–3.
• Severe hyperphosphatemia resulting from high-dose liposomal amphotericin in a child with leukemia. J Pediatr Hematol Oncol. 2003 Apr;25(4):324–6.
• Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia. 2002 Dec;43(12):1488–92.
• Bone health in epilepsy. Epilepsia. 2002 Dec;43(12):1453–4.
• Differential changes of calcium binding proteins in the rat striatum after kainic acid-induced seizure. Neurosci Lett. 2002 Nov 22;333(2):87–90.
• First place winner. Recurrent febrile seizures: an unusual presentation of nutritional rickets. J Emerg Med. 2002 Nov;23(4):367–70.
• Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice. Brain Res Bull. 2002 Oct 15;59(1):53–8.
• Cytoarchitectural abnormalities in hippocampal sclerosis. J Neuropathol Exp Neurol. 2002 Jun;61(6):510–9.
• Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatr Int. 2002 Jun;44(3):247–53.
• Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology. 2002 May 14;58(9):1348–53.
• Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol. 2002 May;59(5):781–6.
• Pathological long-bone fractures in residents with cerebral palsy in a long-term care facility in South Africa. Dev Med Child Neurol. 2002 Feb;44(2):119–22.
• Hurler's syndrome, West's syndrome, and vitamin D-dependent rickets. J Child Neurol. 2002 Feb;17(2):149–51.
• The decreases in calcium binding proteins and neurofilament immunoreactivities in the Purkinje cell of the seizure sensitive gerbils. Neurochem Int. 2002 Feb;40(2):115–22.
• Early induction of secretoneurin expression following kainic acid administration at convulsant doses in the rat and gerbil hippocampus. Hippocampus. 2002;12(2):174–85.
• Synaptic reorganization of calbindin-positive neurons in the human hippocampal CA1 region in temporal lobe epilepsy. Neuroscience. 2002;115(3):961–78.
• Spontaneous recurrent seizures after pilocarpine-induced status epilepticus activate calbindin-immunoreactive hilar cells of the rat dentate gyrus. Neuroscience. 2002;111(1):71–81.
• Cystatin C, a cysteine protease inhibitor, is persistently up-regulated in neurons and glia in a rat model for mesial temporal lobe epilepsy. Eur J Neurosci. 2001 Nov;14(9):1485–91.
• Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci. 2001 Nov;22 Suppl 2:S117–22. Review.
• Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol. 2001 Sep;58(9):1369–74.
• Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia. 2001 Sep;42(9):1141–7.
• Persistent reelin-expressing Cajal-Retzius cells in polymicrogyria. Brain. 2001 Jul;124(Pt 7):1350–61.
• Immunocytochemical analysis of basket cells in rat piriform cortex. J Comp Neurol. 2001 Jun 4;434(3):308–28.
• A new subdivision of anterior piriform cortex and associated deep nucleus with novel features of interest for olfaction and epilepsy. J Comp Neurol. 2001 Jun 4;434(3):289–307.
• Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease? Med Hypotheses. 2001 May;56(5):641–5.
• Transient pseudohypoparathyroidism and neonatal seizure. J Trop Pediatr. 2001 Apr;47(2):113–4.
• Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy. Nat Neurosci. 2001 Jan;4(1):52–62.
• The spiny rat Proechimys guyannensis as model of resistance to epilepsy: chemical characterization of hippocampal cell populations and pilocarpine-induced changes. Neuroscience. 2001;104(4):979–1002.
• Influence of vitamin D administration on bone ultrasound measurements in patients on anticonvulsant therapy. Eur J Clin Invest. 2000 Oct;30(10):895–9.
• Bone mineral density, vitamin D and anticonvulsant therapy. Arq Neuropsiquiatr. 2000 Sep;58(3A):616–20.
• Granule-like neurons at the hilar/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis. J Neurosci. 2000 Aug 15;20(16):6144–58.
• Sulcogyral variation in NMDA receptor 2A/B subunit immunoreactivity in human brain. Neuroreport. 2000 Aug 3;11(11):2601–6.
• Characterization of neuronal migration disorders in neocortical structures: loss or preservation of inhibitory interneurons' Epilepsia. 2000 Jul;41(7):781–7.
• Gonadotropin-dependent sexual precocity in a boy affected by pseudohypoparathyroidism. J Pediatr Endocrinol Metab. 2000 Jul;13 Suppl 1:845–7.
• Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab. 2000 Jul–Aug;13(7):933–9.
• Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care. Dev Med Child Neurol. 2000 Jun;42(6):403–5.
• Microdysgenesis with abnormal cortical myelinated fibres in temporal lobe epilepsy: a histopathological study with calbindin D-28-K immunohistochemistry. Neuropathol Appl Neurobiol. 2000 Jun;26(3):251–7.
• Temporal lobe epilepsy with and without psychosis: exploration of hippocampal pathology including that in subpopulations of neurons defined by their content of immunoreactive calcium-binding proteins. Acta Neuropathol. 2000 May;99(5):547–54.
• Tetany—a first symptom of celiac disease. Tidsskr Nor Laegeforen. 2000 Mar 30;120(9):1034–6.
• The flathead mutation causes CNS-specific developmental abnormalities and apoptosis. J Neurosci. 2000 Mar 15;20(6):2295–306.
• Anticonvulsant induced osteomalacia. Indian Pediatr. 2000 Mar;37(3):325–9.
• Surviving granule cells of the sclerotic human hippocampus have reduced Ca(2+) influx because of a loss of calbindin-D(28k) in temporal lobe epilepsy. J Neurosci. 2000 Mar 1;20(5):1831–6.
• Concentration- and cell type-specific effects of calbindin D28k on vulnerability of hippocampal neurons to seizure-induced injury. Brain Res Mol Brain Res. 2000 Jan 10;75(1):89–95.
• Cerebellar degeneration in hereditary dentatorubral-pallidoluysian atrophy and Machado-Joseph disease. Acta Neuropathol. 2000 Jan;99(1):48–54.
• Changes in bone turnover and deoxypyridinoline levels in epileptic patients. Clin Chem Lab Med. 2000 Jan;38(1):47–50.
• The role of mossy cell death and activation of protein synthesis in the sprouting of dentate mossy fibers: evidence from calretinin and neo-timm staining in pilocarpine-epileptic mice. Epilepsia. 2000;41 Suppl 6:S18–23.
• Early loss of interneurons and delayed subunit-specific changes in GABA(A)-receptor expression in a mouse model of mesial temporal lobe epilepsy. Hippocampus. 2000;10(3):305–24.
• Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin. Neuroscience. 2000;97(1):47–58.
• Changes in the distribution and connectivity of interneurons in the epileptic human dentate gyrus. Neuroscience. 2000;96(1):7–25.
• Reduced density of parvalbumin- and calbindin D28-immunoreactive neurons in experimental cortical dysplasia. Epilepsy Res. 1999 Oct;37(1):63–71.
• Epilepsy and pregnancy. Tidsskr Nor Laegeforen. 1999 Sep 30;119(23):3437–40. Review.
• Taylor's cortical dysplasia: a confocal and ultrastructural immunohistochemical study. Brain Pathol. 1999 Jul;9(3):445–61.
• Responses of heat shock proteins hsp27, alphaB-crystallin, and hsp70 in rat brain after kainic acid-induced seizure activity. J Neurochem. 1999 Jul;73(1):229–36.
• Disease caused by lack of sunlight: rickets and osteomalacia. Ned Tijdschr Geneeskd. 1999 Mar 20;143(12):593–7. Review.
• Characterization of nodular neuronal heterotopia in children. Brain. 1999 Feb;122 ( Pt 2):219–38.
• An increase of hippocampal calretinin-immunoreactive neurons correlates with early febrile seizures in temporal lobe epilepsy. Acta Neuropathol. 1999 Jan;97(1):31–9.
• Heterotopic neurogenesis in a rat with cortical heterotopia. J Neurosci. 1998 Nov 15;18(22):9365–75.
• Nonobligate role of early or sustained expression of immediate-early gene proteins c-fos, c-jun, and Zif/268 in hippocampal mossy fiber sprouting. J Neurosci. 1998 Nov 15;18(22):9245–55.
• Inhibitory function in two models of chronic epileptogenesis. Epilepsy Res. 1998 Sep;32(1–2):83–92.
• Rickets presenting as seizures in the emergency department: medico-cultural implications. Pediatr Emerg Care. 1998 Jun;14(3):215–6.
• Calcium-dependent inactivation of high-threshold calcium currents in human dentate gyrus granule cells. J Physiol. 1998 May 15;509 ( Pt 1):39–45.
• Laminar distribution of Fos/calcium-binding protein and Fos/neurofilament protein-labeled neurons in rat motor and sensory cortex after picrotoxin-induced seizures. Exp Neurol. 1998 Feb;149(2):373–83.
• Cortical dysplasia: an immunocytochemical study of three patients. Neurology. 1998 Jan;50(1):27–36.
• Carbamazepine and vigabatrin in epileptic pregnant woman and side effects in the newborn infant. Arch Pediatr. 1997 Oct;4(10):975–8.
• Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol. 1997 Oct;56(10):1119–24.
• Connections of the hippocampal formation in humans: I. The mossy fiber pathway. J Comp Neurol. 1997 Sep 1;385(3):325–51.
• Parvalbumin- and calbindin-containing neurons express c-fos protein in primary and secondary (mirror) epileptic foci of the rat neocortex. Brain Res. 1997 Jun 27;761(1):135–45.
• Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status. Am J Clin Nutr. 1997 Apr;65(4):1042–51.
• Vitamin D deficiency in pregnant and breast-feeding women and their infants. J Perinatol. 1997 Jan–Feb;17(1):10–4.
• Loss of Calbindin-D28K immunoreactivity from dentate granule cells in human temporal lobe epilepsy. Neuroscience. 1997 Jan;76(2):377–85.
• Delayed decrease of calbindin immunoreactivity in the granule cell-mossy fibers after kainic acid-induced seizures. Brain Res Bull. 1997;43(6):551–9.
• Studies on nutrition in severely neurologically disabled children in an institution. Acta Paediatr. 1996 Dec;85(12):1469–75.
• The calretinin-containing mossy cells survive excitotoxic insult in the gerbil dentate gyrus. Comparison of excitotoxicity-induced neuropathological changes in the gerbil and rat. Eur J Neurosci. 1996 Nov;8(11):2371–8.
• Calbindin-D28K-immunoreactive cells and fibres in the human amygdaloid complex. Neuroscience. 1996 Nov;75(2):421–43.
• Idiopathic hypoparathyroidism. Presentation of a case. An Med Interna. 1996 Jul;13(7):354–5.
• Preservation of calretinin-immunoreactive neurons in the hippocampus of epilepsy patients with Ammon's horn sclerosis. J Neuropathol Exp Neurol. 1996 Mar;55(3):329–41.
• Alteration in levels of expression of brain calbindin D-28k and calretinin mRNA in genetically epilepsy-prone rats. Epilepsia. 1995 Sep;36(9):911–21.
• Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies. J Neuropathol Exp Neurol. 1995 Sep;54(5):689–97.
• A light and electron microscopic study of calbindin D-28k immunoreactive double bouquet cells in the human temporal cortex. Brain Res. 1995 Aug 28;690(1):133–40.
• Vitamin D deficiency rickets in breast-fed infants presenting with hypocalcaemic seizures. Acta Paediatr. 1995 Aug;84(8):941–2.
• Therapy-resistant seizures in pseudohypoparathyroidism. A case report. J Pediatr Endocrinol Metab. 1995 Jul–Sep;8(3):209–11.
• Neuronal injury following electrically induced status epilepticus with and without adenosine receptor antagonism. Exp Neurol. 1995 Jun;133(2):125–37.
• Unusual complications of rickets. Indian Pediatr. 1995 Jun;32(6):697–8.
• Delayed cell death in the contralateral hippocampus following kainate injection into the CA3 subfield. Neuroscience. 1995 Jun;66(4):847–60.
• Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev. 1994 Sep–Oct;16(5):382–5.
• Spasmus nutans. A re-emergent pathology' Minerva Pediatr. 1994 Jul–Aug;46(7–8):351–4.
• Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res. 1994 May;9(5):631–7.
• Parvalbumin and calbindin-D28k immunocytochemistry in human neocortical epileptic foci. J Neurol Sci. 1994 May;123(1–2):18–25.
• Metabolism and action of vitamin D in epileptic patients on anticonvulsive treatment and healthy adults. Dan Med Bull. 1994 Apr;41(2):139–50. Review.
• Convulsions and neonatal hypoparathyroidism revealing maternal hyperparathyroidism. Arch Pediatr. 1994 Mar;1(3):255–9.
• Transient decrease in calbindin immunoreactivity of the rat fascia dentata granule cells after repeated electroconvulsive shocks. Hippocampus. 1994 Feb;4(1):79–83.
• Abnormal bone mineral metabolism after long-term anticonvulsant treatment. Ann Pharmacother. 1994 Jan;28(1):47–8.
• Selective neuronal death in the contralateral hippocampus following unilateral kainate injections into the CA3 subfield. Neuroscience. 1993 Sep;56(2):317–35.
• Seizures and acute death attributable to hypovitaminosis A and suspected hypovitaminosis D in feeder pigs. J Am Vet Med Assoc. 1993 Apr 15;202(8):1276–8.
• Abnormal local-circuit neurons in epilepsia partialis continua associated with focal cortical dysplasia. Acta Neuropathol. 1992;83(6):647–52.
• Pattern of neuronal death in the rat hippocampus after status epilepticus. Relationship to calcium binding protein content and ischemic vulnerability. Brain Res Bull. 1992 Jan;28(1):27–38.
• Endogenous intracellular calcium buffering and the activation/inactivation of HVA calcium currents in rat dentate gyrus granule cells. J Gen Physiol. 1991 Nov;98(5):941–67.
• Neuropeptide Y (NPY)-immunoreactive neurons in the primate fascia dentata; occasional coexistence with calcium-binding proteins: a light and electron microscopic study. J Comp Neurol. 1991 Jul 22;309(4):430–44.
• Serum osteocalcin concentration in a patient with pseudohypoparathyroidism type Ib. Nippon Naibunpi Gakkai Zasshi. 1991 Jul 20;67(7):775–84.
• Calcium-binding protein (calbindin-D28K) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J Comp Neurol. 1991 Jun 15;308(3):381–96.
• Calcium binding protein (calbindin-D28k) and glutamate decarboxylase gene expression after kindling induced seizures. Brain Res Mol Brain Res. 1991 Feb;9(3):179–90.
• A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. Q J Med. 1991 Feb;78(286):113–22.
• Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: the "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus. 1991 Jan;1(1):41–66.
• Hypocalcemic focal seizures in a one-month-old infant of a mother with a low circulating level of vitamin D. Brain Dev. 1991;13(2):132–4.
• Calbindin-D28K (CaBP) levels and calcium currents in acutely dissociated epileptic neurons. Exp Brain Res. 1991;85(3):543–51.
• A case of adult-onset spike-wave stupor associated with hypoparathyroidism and hyperostosis frontalis interna (HFI). Rinsho Shinkeigaku. 1990 Oct;30(10):1114–7.
• Anticonvulsant agents and osteomalacia. Med J Aust. 1990 Mar 5;152(5):279–80.
• Parvalbumin, molecular and functional aspects. Adv Exp Med Biol. 1990;269:57–66. Review.
• Antiepileptic drugs, hepatic enzyme induction and raised serum alkaline phosphatase isoenzymes. Int J Clin Pharmacol Res. 1990;10(6):319–23.
• Long-term nutritional status of an enterally nourished institutionalized population. Am J Clin Nutr. 1989 Aug;50(2):381–90.
• Influence of solar irradiation on vitamin D levels in children on anticonvulsant drugs. Acta Neurol Scand. 1989 Apr;79(4):296–9.
• Spontaneous hypoparathyroidism: clinical, biochemical and radiological features. Indian J Pediatr. 1989 Mar–Apr;56(2):267–72.
• Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry: localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J Comp Neurol. 1989 Feb 8;280(2):183–96.
• Anticonvulsant-induced osteomalacia (review of the literature). Zh Nevropatol Psikhiatr Im S S Korsakova. 1989;89(8):122–7. Review.
• Bone status in nonambulant, epileptic, institutionalized youth. Improvement with vitamin D therapy. Clin Pediatr (Phila). 1988 Oct;27(10):499–505.
• Osteopathia antiepileptica in adolescents and adults. Fortschr Neurol Psychiatr. 1988 Jul;56(7):216–30. Review.
• Pathologic fractures in a patient with renal osteodystrophy. Failure of early detection on bone scans. Clin Nucl Med. 1987 Jul;12(7):510–3.
• Distribution of Calbindin-D28K 1 (CaBP) in the cerebral cortex and hippocampus of the epileptic (El) mouse. Epilepsy Res. 1987 Jan;1(1):46–52.
• Increased serum creatine kinase due to hypocalcemia in vitamin D deficiency. Pediatr Neurol. 1987 Jan–Feb;3(1):37–9.
• Factors associated with the biochemical changes in vitamin D and calcium metabolism in institutionalized patients with epilepsy. Ir J Med Sci. 1986 Jun;155(6):181–9.
• A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med. 1986 Jun;59(230):569–77.
• Hypocalcemia in childhood. Pediatriia. 1986 May;(5):71–5. Review.
• Vitamin D2 therapy of pseudohypoparathyroidism. Assessment of non-compliance. Clin Pediatr (Phila). 1986 Jan;25(1):49–52.
• Pancreatic secretion in man with subclinical vitamin D deficiency. Diabetologia. 1986 Jan;29(1):34–8.
• Fractures caused by epileptic seizures and epileptic osteomalacia. Injury. 1986 Jan;17(1):31–3.
• Different metabolism of vitamin D2/D3 in epileptic patients treated with phenobarbitone/phenytoin. Bone. 1986;7(5):337–42.
• Different metabolism of vitamin D2 and vitamin D3 in epileptic patients on carbamazepine. Acta Neurol Scand. 1985 May;71(5):385–9.
• Hormone binding globulins and anticonvulsant therapy. Scott Med J. 1985 Apr;30(2):101–5.
• The effects of long-term anticonvulsant drug therapy on vitamin D metabolites and mineral homeostasis in pregnant epileptic women and their newborns. Ann Chir Gynaecol Suppl. 1985;197:37–41.
• Side effects of antiepileptic drugs. Neurol Neurochir Pol. 1984 Nov–Dec;18(6):575–81. Review.
• Serum concentrations of phenobarbital and the metabolism of calcium and phosphorus in children. Rev Chil Pediatr. 1984 Nov–Dec;55(6):407–10.
• Anticonvulsant drug therapy in human pregnancy: effects on serum concentrations of vitamin D metabolites in maternal and cord blood. Am J Obstet Gynecol. 1984 Oct 1;150(3):254–8.
• Carbamazepine and bone mineral metabolism. Acta Neurol Scand. 1984 Aug;70(2):77–80.
• Vitamin D metabolism and anticonvulsant therapy: effect of sunshine on incidence of osteomalacia. South Med J. 1984 Jul;77(7):834–6, 842.
• Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab. 1984 Jun;58(6):1003–9.
• Prevalence of hypocalcemia and elevated serum alkaline phosphatase in patients receiving chronic anticonvulsant therapy. J Fam Pract. 1984 Jun;18(6):873–7.
• Administration of 1,25-dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats. Brain Res. 1984 Apr 23;298(1):125–9.
• Is there justification for additional prevention using vitamin D in therapy with barbiturates' Lijec Vjesn. 1984 Apr;106(4):147–51.
• Serum dihydroxyvitamin D metabolite concentrations in patients on chronic anticonvulsant drug therapy: response to pharmacologic doses of vitamin D2. Metab Bone Dis Relat Res. 1983–1984;5(1):1–6.
• Effect of vitamin D2 and D3 on bone-mineral content in carbamazepine-treated epileptic patients. Acta Neurol Scand. 1983 Dec;68(6):424–8.
• Antiepileptic-induced osteomalacia and vitamin D therapy. Nervenarzt. 1983 Dec;54(12):647–50.
• Hypocalcaemic seizures following gastrectomy. Eur J Pediatr. 1983 Oct;141(1):36–8.
• Accumulation of aluminum in a nondialyzed uremic child receiving aluminum hydroxide. Pediatrics. 1983 Jan;71(1):56–8.
• Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D. Q J Med. 1983 Winter;52(205):79–91.
• Pathophysiology behind anticonvulsant osteomalacia. Acta Neurol Scand Suppl. 1983;94:21–8.
• Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy. Acta Neurol Scand Suppl. 1983;97:69–80.
• Disorders of calcium metabolism and ossification caused by anticonvulsants. Padiatr Padol. 1983;18(2):119–21.
• Controlled trials in epilepsy: a review. Epilepsia. 1982 Oct;23(5):491–519. Review.
• Diminished bone turnover in patients treated with anticonvulsants. Med Clin (Barc). 1982 Sep 16;79(5):224–6.
• Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants. Acta Neurol Scand. 1982 Sep;66(3):335–41.
• Anticonvulsant osteomalacia in epileptic outpatients. Ann Clin Res. 1982 Jun;14(3):129–32.
• Altered vitamin-D metabolism due to anticonvulsant drugs in epileptic children. Indian Pediatr. 1982 Jun;19(6):489–92.
• Rickets in children induced by anticonvulsant therapy. Pediatriia. 1982 Jun;(6):75–7. Review.
• Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy. Ann Clin Res. 1982 Apr;14(2):72–5.
• Response of kidney and bone to parathyroid hormone in children receiving anticonvulsant drugs. Neuropediatrics. 1982 Feb;13(1):3–9.
• Dialysis encephalopathy and osteomalacic bone disease: a case-controlled study. Am J Med. 1982 Jan;72(1):33–42.
• Inhibitory effect of calcium on serum prolactin. Acta Endocrinol (Copenh). 1981 Nov;98(3):339–44.
• Factors causing rickets in institutionalised handicapped children on anticonvulsant therapy. Arch Dis Child. 1981 Jun;56(6):446–9.
• Epilepsy and hypocalcemia. Further considerations on a case. Acta Neurol (Napoli). 1981 Feb;3(1):11–6.
• Phenytoin: pharmacokinetics and clinical therapeutics. Neurosurgery. 1981 Jan;8(1):112–7.
• Epilepsy and hypocalcemia. Further considerations on a case. Acta Neurol [Quad] (Napoli). 1981;42:11–6.
• Folic acid and vitamin D status of young children receiving minimal anticonvulsant drug therapy. Int J Vitam Nutr Res. 1981;51(4):349–52.
• Folate and mineral metabolism in poorly nourished epileptic children. Arch Neurol. 1980 Dec;37(12):772–4.
• Delayed response to a alpha-hydroxycholecalciferol therapy in a case of hypoparathyroidism during anticonvulsant therapy. Isr J Med Sci. 1980 Nov;16(11):772–4.
• Do newborns of epileptics on anticonvulsants develop biochemical signs of osteomalacia' Acta Neurol Scand. 1980 Sep;62(3):158–64.
• Prompt resolution of osteomalacia by switching from phenytoin to phenobarbital. Arch Intern Med. 1980 Jun;140(6):852.
• Idiopathic hypoparathyroidism and convulsive seizures Riv Neurol. 1980 Jan–Feb;50(1):56–66.
• Amicrobic pustulosis hypoparathyroidism epilepsy: treatment by 25-hydroxycholecalciferol. Ann Dermatol Venereol. 1980;107(12):1145–50.
• Competitive protein binding assay for plasma 25-hydroxycholecalciferol. Methods Enzymol. 1980;67:466–72.
• Transient hypoparathyroidism as a cause of spasms in the newborn. Padiatr Grenzgeb. 1980;19(5):299–302.
• Anticonvulsants and osteopenia. Rev Clin Esp. 1979 Oct 15;155(1):43–5.
• Hypercalcaemia in rheumatoid arthritis: investigation of its causes and implications. Ann Rheum Dis. 1979 Oct;38(5):401–12.
• Renal failure and rickets. Bol Med Hosp Infant Mex. 1979 Sep–Oct;36(5):901–7.
• Decreased serum 24,25-dihydroxy vitamin D concentrations in children receiving chronic anticonvulsant therapy. Br Med J. 1979 Sep 1;2(6189):521–3.
• Anticonvulsants and vitamin D metabolism in epileptic children. Med J Osaka Univ. 1979 Sep;30(1–2):31–8.
• Disordered mineral metabolism produced by ketogenic diet therapy. Calcif Tissue Int. 1979 Aug 24;28(1):17–22.
• The medical treatment of epilepsy: antiepileptic drug interactions and teratogenicity. Pediatr Ann. 1979 Apr;8(4):267–74.
• Serum concentrations of 25-hydroxyvitamin D in Florida children: effect of anticonvulsant drugs. South Med J. 1979 Apr;72(4):400–1, 408.
• Anticonvulsant drug-induced osteomalacia: alterations in mineral metabolism and response to vitamin D3 administration. Calcif Tissue Int. 1979 Mar 13;27(1):13–8.
• Antiepileptic drugs and vitamin D supplementation. Epilepsia. 1979 Feb;20(1):3–15.
• Pseudo-vitamin D deficiency rickets: report of a case. Helv Paediatr Acta. 1979;34(5):461–4.
• Disturbances of calcium-phosphate-metabolism by anticonvulsant drugs in relation to their serum concentration (author's transl). Padiatr Padol. 1979;14(1):89–95.
• Studies of hypoparathyroidism and pseudohypoparathyroidism. Q J Med. 1978 Oct;47(188):533–48.
• Anticonvulsive treatment and calcium metabolism. Psychiatr Neurol Med Psychol (Leipz). 1978 Sep;30(9):533–44.
• A case of osteomalacia secondary to prolonged treatment with anticonvulsant drugs. Clin Ter. 1978 Jun 30;85(6):573–90.
• Epilepsy and pregnancy (author's transl). Schweiz Rundsch Med Prax. 1978 Jun 6;67(23):848–53.
• Metabolic and immunological disorders induced by long-term treatment with phenytoin. Neurol Neurochir Pol. 1978 May–Jun;12(3):321–5. Review.
• Neonatal hypocalcaemia associated with maternal hyperparathyroidism. New pathogenetic observations. Arch Dis Child. 1978 Apr;53(4):308–11.
• Neonatal convulsions: aetiology, late neonatal status and long-term outcome. Dev Med Child Neurol. 1978 Apr;20(2):143–8.
• Serum alkaline phosphatase isoenzymes in epileptic children receving anticonvulsant drugs. Eur J Pediatr. 1977 Nov 4;126(4):237–42.
• Lack of response to vitamin D therapy in a patient with hypoparathyroidism under anticonvulsant drugs. Helv Paediatr Acta. 1977 Nov;32(4–5):369–73.
• Hypocalcaemia and convulsions. Postgrad Med J. 1977 Jun;53(620):330–3.
• Height alterations and calcium metabolism after prolongated phenobarbital treatment (author's transl). An Esp Pediatr. 1977 May;10(5):441–6.
• Interactions with antiepileptic drugs. Drugs. 1977 Apr;13(4):266–75. Review.
• Barbiturates and serum calcium in the elderly. Postgrad Med J. 1977 Apr;53(618):212–5.
• Handskeleton studies with mammography technique in patients under antiepileptic medication (author's transl). Rofo. 1977 Apr;126(4):371–5.
• The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia. Acta Endocrinol (Copenh). 1977 Mar;84(3):559–65.
• Rickets in children receiving anticonvulsant drugs. Biochemical and hormonal markers. Am J Dis Child. 1977 Mar;131(3):286–90.
• Evidence of osteomalacia in an outpatient group of adult epileptics. Epilepsia. 1977 Mar;18(1):37–43.
• Neonatal hypocalcemia in hyperparathyroidism of the mother (author's transl). Klin Padiatr. 1977 Mar;189(2):185–91.
• Effect of long-term vitamin D2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia. Acta Med Scand. 1977;201(4):303–7.
• Phenytoin, phenobarbitone and serum cholesterol. Scand J Soc Med. 1977;5(3):123–5.
• Effects of diphenylhydantoin in 41 epileptics institutionalized since childhood. South Med J. 1977 Jan;70(1):19–24.
• Feuerstein and Mims syndrome with resistant rickets. Pediatr Radiol. 1976 Dec 15;5(2):120–2.
• Critical remarks on the concept of "osteopathia antiepileptica." Psychiatr Neurol Med Psychol (Leipz). 1976 Sep;28(9):538–47. Review.
• Differential diagnosis of cerebral convulsive seizures in the tetanic syndrome. Psychiatr Neurol Med Psychol (Leipz). 1976 Aug;28(8):458–65.
• Serum calcium balance during early phase of diphenylhydantoin therapy. Int J Clin Pharmacol Biopharm. 1976 Jul;14(1):15–9.
• Linear sebaceous naevi with convulsions and mental retardation (Feuerstein-Mims' syndrome), vitamin-D-resistant rickets. Proc R Soc Med. 1976 Jul;69(7):518–20.
• New knowledge about vitamin D and fluorides. Zahnarztl Mitt. 1976 Jun 1;66(11):546–50.
• Vitamin D: the discovery of its metabolites and their therapeutic applications. Pediatrics. 1976 May;57(5):729–41. Review.
• Vitamin D deficiency. Osteopathy after prolonged treatment with anticonvulsents (author's transl). Rofo. 1976 Jan;124(1):7–11.
• Anticonvulsant osteomalacia determined by quantitative analysis of bone changes. Population study and possible risk factors. Acta Med Scand. 1976;199(5):349–55.
• Enzyme-inducing agents and their effect on vitamin D metabolism. Front Gastrointest Res. 1976;2:32–70. Review.
• Pathogenesis of osteopathy caused by anticonvulsives (author's transl). Padiatr Padol. 1976;11(3):528–38.
• Bone metabolic disorders after prolonged treatment with antiepileptic agents in a patient with idiopathic hypoparathyroidism. Vutr Boles. 1976;15(5):93–7.
• 4 cases of osteomalacia during anticonvulsant or sedative treatment. Sem Hop. 1975 Dec 23;51(49):3019–27.
• Osteomalacy induced by anticonvulsants. One case with a study of vitamin D metabolism. Nouv Presse Med. 1975 Dec 20;4(44):3121–4.
• The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. J Clin Endocrinol Metab. 1975 Dec;41(06):1130–5.
• Calcium and folic acid absorption in patients taking anticonvulsant drugs. J Clin Endocrinol Metab. 1975 Dec;41(06):1125–9.
• The effect of long term anticonvulsant therapy on serum calcium, phosphate and alkaline phosphatase in Nigerian epileptic patients. Trop Geogr Med. 1975 Dec;27(4):418–21.
• Modifications of phosphocalcic metabolism in patients treated with anticonvulsivants (author's transl). An Esp Pediatr. 1975 Nov–Dec;8(6):626–9.
• Anticonvulsant osteomalacia. J R Coll Surg Edinb. 1975 Nov;20(6):380–3.
• Biochemical status in epileptic patients during treatment with vitamin D. A controlled therapeutic trial. Acta Neurol Scand. 1975 Aug;52(2):81–6.
• Subjective symptoms in epileptic patients on anticonvulsant drugs. A controlled therapeutic trial on the effect of vitamin d. Acta Neurol Scand. 1975 Aug;52(2):87–93.
• Serum alkaline phosphatase and urinary hydroxyproline values in children receiving phenobarbital with and without vitamin D. J Pediatr. 1975 Aug;87(2):291–6.
• Osteomalacia presenting as chorea. Br Med J. 1975 Jul 19;3(5976):136–8.
• Anticonvulsant osteomalacia. Arch Intern Med. 1975 Jul;135(7):997–1000.
• Recent clinical correlates of vitamin D metabolites and calcium metabolism. Nutr Rev. 1975 Jul;33(7):209–10. Review.
• Anti-epileptic drugs: some factors influencing absorption and metabolism. Drug Ther Bull. 1975 Jun 6;13(12):47–8.
• Vitamin D supplements: requirements in special circumstances in children. Can Med Assoc J. 1975 May 17;112(10):1216.
• Calcium metabolism disorders during hydantoinal treatment. Pol Tyg Lek. 1975 Apr 28;30(17):731–2.
• Osteoporosis and osteomalacia. Schweiz Med Wochenschr. 1975 Apr 12;105(15):466–70.
• Vitamin D therapy: problems and prospects. Drug Ther Bull. 1975 Apr 11;13(8):29–31.
• Iatrogenic osteomalacia in epileptic children. A controlled therapeutic trial. Acta Paediatr Scand. 1975 Mar;64(2):219–24.
• Rickets in Tehran. Study of 200 cases. Arch Dis Child. 1975 Jan;50(1):63–6.
• Effects of anticonvulsants and inactivity on bone disease in epileptics. Postgrad Med J. 1975 Jan;51(591):18–21.
• Therapy with 25-hydroxycholecalcipherol (25-HCC) in calcium resorption errors during anti-epileptic treatment. Bibl Psychiatr. 1975;(151):151–5.
• Vitamin D- and calcium metabolic errors during anti-epileptic therapy. Bibl Psychiatr. 1975;(151):144–50.
• Osteopathies, calcium- and vitamin D metabolism errors during anti-epileptic long term therapy. Bibl Psychiatr. 1975;(151):114–43. Review.
• Maternal anticonvulsants and perinatal risk. Eur J Obstet Gynecol Reprod Biol. 1975;5(5):277–82.
• Vitamin D resistant rickets in children with epilepsy. Neuropsihijatrija. 1975;23(1–4):93–7.
• Iatrogenic nutritional effects of anticonvulsants. Proc Nutr Soc. 1974 Dec;33(3):225–9.
• Myopathy and osteomalacia after longterm antiepileptic treatment (author's transl). MMW Munch Med Wochenschr. 1974 Nov 29;116(48):2113–6.
• Vitamin D-an old hormone rediscovered. Scott Med J. 1974 Nov;19(6):247–9.
• Anticonvulsants and vitamin D metabolism (author's transl). MMW Munch Med Wochenschr. 1974 Sep 13;116(37):1579–84.
• Topical clinical problems of vitamin D research (author's transl). MMW Munch Med Wochenschr. 1974 Sep 13;116(37):1565–8. Review.
• Primary infantile hypomagnesaemia. Proc R Soc Med. 1974 Aug;67(8):759–60.
• Rickets and osteomalacia induced by anticonvulsant drugs. Harefuah. 1974 May 15;86(10):501–2.
• "Anticonvulsant action" of vitamin D in epileptic patients? A controlled pilot study. Br Med J. 1974 May 4;2(5913):258–9.
• Congestive heart failure secondary to idiopathic hypoparathyroidism. Am J Dis Child. 1974 May;127(5):738–9.
• "Antiepileptic therapy" rickets roentgenologic implications. Ann Radiol (Paris). 1974 May–Jun;17(4):375–83.
• Prevalence and treatment of vitamin D deficiency in children on anticonvulsant drugs. Arch Dis Child. 1974 May;49(5):344–50.
• An unusual cause of failure to thrive. Clin Pediatr (Phila). 1974 Apr;13(4):379–80.
• Inter-relationships of nutrition and the metabolism of drugs. Chem Biol Interact. 1974 Mar;8(3):193–206. Review.
• Magnesium in the nutrition of the child. Clin Pediatr (Phila). 1974 Mar;13(3):263–7 passim. Review.
• Myopathy and elevated serum enzymes in a case of hypoparathyroidism. Z Kinderheilkd. 1974 Feb 11;116(3):193–6.
• Rickets associated with anticonvulsant medication. Pediatrics. 1974 Jan;53(1):91–5.
• Effects of long-term anticonvulsant therapy on calcium and vitamin D metabolism. Proc R Soc Med. 1974 Jan;67(1):64–8.
• Development of anticonvulsant osteomalacia in epileptic patients on phenytoin treatment. Acta Neurol Scand. 1974;50(4):527–32.
• Clinical phenotypes in kidney transport disorders. Birth Defects Orig Artic Ser. 1974;10(4):118–26.
• Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. Br Med J. 1973 Dec 22;4(5894):695–701.
• The clinical application of a chromatographic semiquantitative method for the determination of the vitamin-D level in blood (author's transl). Wien Klin Wochenschr. 1973 Dec 7;85(49):809–11.
• Vitamin D-dependency rickets in institutionalized, mentally retarded children on long term anticonvulsant therapy. II. The response to 25-hydroxycholecalciferol and to vitamin D2. Pediatr Res. 1973 Nov;7(11):914–22.
• Proceedings: Study of enzyme induction in epileptic children. Arch Dis Child. 1973 Oct;48(10):831.
• Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients. J Pediatr. 1973 Oct;83(4):612–20.
• Effects of antiepileptic drugs in pregnancy on the fetus and newborn infant. Ann Clin Res. 1973 Aug;5(4):205–7. Review.
• Osteomalacia due to phenytoin sodium. A case report with review of literature. J Neurol Sci. 1973 Jul;19(3):287–95.
• Vitamin D requirements in atypical forms of rickets. Monatsschr Kinderheilkd. 1973 Jul;121(7):362–4.
• Anticonvulsant drugs and vitamin D metabolism. JAMA. 1973 Jun 18;224(12):1634–5.
• Rickets precipitated by anticonvulsant drugs in a child receiving prophylactic vitamin D. Am J Dis Child. 1973 Jun;125(6):850–2.
• Diphenylhydantoin and rickets. Lancet. 1973 May 19;1(7812):1119.
• Effect of vitamin D on bone mineral mass in normal subjects and in epileptic patients on anticonvulsants: a controlled therapeutic trial. Br Med J. 1973 Apr 28;2(5860):208–9.
• A complicated case of convulsions. Clin Pediatr (Phila). 1973 Mar;12(3):187–8.
• Antiepileptic drugs and development of rickets. J Pediatr. 1973 Feb;82(2):347–8.
• Distinct rickets during anticonvulsant long-term therapy. Kinderarztl Prax. 1973 Feb;41(2):76–80.
• Frequency of rickets-like bone lesions during anticonvulsive therapy. Kinderarztl Prax. 1973 Feb;41(2):71–6.
• Vitamin D. Fascinating research results in relation to the anti-epileptics. Tidsskr Nor Laegeforen. 1973 Jan 30;93(3):191–3.
• Disordered calcium metabolism during anticonvulsant treatment. Ger Med. 1973 Winter;3(3–4):140–4. Review.
• Vitamin D in patients on anticonvulsants. Br Med J. 1972 Dec 2;4(5839):547.
• Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat. Epilepsia. 1972 Dec;13(6):829–34.
• Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med. 1972 Nov 2;287(18):900–4.
• Anticonvulsant osteomalacia. Lancet. 1972 Oct 14;2(7781):805–6.
• Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs. Br Med J. 1972 Oct 7;4(5831):9–12.
• Pseudohypoparathyroidism with paradoxical increase in hypocalcaemic seizures due to long-term anticonvulsant therapy. Postgrad Med J. 1972 Oct;48(564):632–6.
• Latent osteomalacia in epileptic patients on anticonvulsants. Br Med J. 1972 Sep 23;3(5829):738–9.
• Osteomalacia accompanying chronic anticonvulsant therapy. J Clin Endocrinol Metab. 1972 Sep;35(3):378–86.
• Intestinal absorption of vitamin D 3 in epileptic patients and phenobarbital-treated rats. Epilepsia. 1972 Aug;13(4):509–19.
• Pseudohypoparathyroidism. A review on the differential diagnosis based on own observation. Monatsschr Kinderheilkd. 1972 Aug;120(8):319–24.
• Long-term administration of antiepileptic drugs and the development of rickets. J Pediatr. 1972 Jul;81(1):9–15.
• Vitamin D metabolism and antiepileptics. Schweiz Med Wochenschr. 1972 Jun 10;102(23):785–91.
• Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J. 1971 Oct 23;4(5781):202–4.
• Osteomalacia and anticonvulsant drugs. Nutr Rev. 1971 Feb;29(2):38–41. Review.
• Hypocalcemias of the newborn. J Med Liban. 1971;24(4):427–32.
• Pseudo-vitamin D deficiency rickets: a case report. Turk J Pediatr. 1971 Jan;13(1):1–8.
• Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J. 1970 Oct 10;4(5727):73–6.
• Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J. 1970 Oct 10;4(5727):69–72.
• Tetany in infants. Recenti Prog Med. 1970 Jan;48(1):34–44.
• Therapy of occasional convulsions in children and adolescents. Munch Med Wochenschr. 1969 Sep 5;111(36):1803–6.
• Congenital hypoparathyroidism simulating epilepsy, with other symptoms and dental signs of intra-uterine hypocalcemia. Pediatrics. 1969 Sep;44(3):401–9.
• Case of idiopathic hypoparathyroidism associated with calcification of the basal ganglia. No To Shinkei. 1969 Feb;21(2):193–7.
• Idiopathic transitory hypoparathyroidism in young infants. Arch Fr Pediatr. 1968 Dec;25(10):1151–70.
• Hypoparathyroidism. Solved and unsolved pathologic physiological problems. Dtsch Med Wochenschr. 1968 Jul 19;93(29):1383–9.
• Primary hypomagnesemia with secondary hypocalcemia in an infant. Pediatrics. 1968 Feb;41(2):385–402.
• Familial hypoparathyroidism. Case reports and a eview of the literature. Neurology. 1968 Jan;18(1 Pt 1):75–80.
• Hypoparathyroidism. Clinical observations in 34 patients. Arch Intern Med. 1967 Oct;120(4):449–58.
• Transient congenital idiopathic hypoparathyroidism. Helv Paediatr Acta. 1967 Aug;22(4):342–59.
• An unusual neurological manifestation of hypocalcaemia. Lancet. 1967 Mar 4;1(7488):475–7.
• Tetany of early infancy as an expression of a transitory, idiopathic hypoparathyroidism. Z Kinderheilkd. 1967;99(3):211–23. Review.
• Modern therapy of seizures in childhood. Z Arztl Fortbild (Jena). 1964 Mar 15;58:308–15.
• Additional therapeutic possibilities in chronic epileptic seizures. Med Welt. 1963 Nov 9;45:2290–5.
• Subcortical tonic epilepsy type of seizure, with intracerebral calcareous deposits and parathyroid insufficiency suppressed by calciferol; physiopathological nosological and etiological discussion: possible role of carbon monoxide poisoning. Ann Med Interne (Paris). 1954;55(4):321–59.

back to research menu